China Health Group Limited (HKG:0673)
0.3400
+0.0100 (3.03%)
Jul 22, 2025, 3:19 PM HKT
China Health Group Revenue
In the fiscal year ending March 31, 2025, China Health Group had annual revenue of 38.94M HKD, down -35.02%. China Health Group had revenue of 20.26M in the half year ending March 31, 2025, a decrease of -54.04%.
Revenue
38.94M
Revenue Growth
-35.02%
P/S Ratio
4.29
Revenue / Employee
263.13K
Employees
148
Market Cap
167.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 38.94M | -20.99M | -35.02% |
Mar 31, 2024 | 59.93M | -16.48M | -21.57% |
Mar 31, 2023 | 76.41M | -30.61M | -28.60% |
Mar 31, 2022 | 107.03M | 19.14M | 21.77% |
Mar 31, 2021 | 87.89M | 42.73M | 94.62% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |